News Conference News EuroPCR 2021 Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry Todd Neale May 20, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Conference News SCAI 2021 Harmony TPV Continues to Reduce Pulmonary Valve Regurgitation at 1 Year Yael L. Maxwell May 04, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2021 Caitlin E. Cox May 03, 2021
News Daily News New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research Michael O'Riordan April 23, 2021
News Conference News CRT 2021 Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows Michael O'Riordan March 09, 2021
News Daily News Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients Yael L. Maxwell March 02, 2021
News Daily News Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution L.A. McKeown January 22, 2021
News Daily News TAVI vs Minimally Invasive AVR Yields Surprising Findings: Meta-analysis Yael L. Maxwell January 22, 2021
News Daily News CMS Extends MitraClip Coverage to Functional MR, Carves Out Imager Role Shelley Wood January 20, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2020 Shelley Wood December 31, 2020
News Opinion Editor's Corner Envision Change: A Different Future for Cardiology, Medicine, Research, and Health Shelley Wood December 29, 2020
News Daily News New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR Caitlin E. Cox December 23, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Daily News CAD Common in MitraClip Patients, but When and If to Fix Are Unclear Shelley Wood December 03, 2020
News Conference News PCR London Valves 2020 No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION Shelley Wood November 26, 2020
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020